Editorial: Mitigating the Risk of Adverse Pregnancy Outcomes in Women With Inflammatory Bowel Disease and Chronic Liver Disease—Authors' Reply

Ähnliche Einträge

• Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver Disease
  von: Jessica D. Lee, et al.
  Veröffentlicht: (2025)
• Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
  von: Konstantinos Papamichael, et al.
  Veröffentlicht: (2024)
• Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease—Authors' Reply
  von: Isabel Carbery, et al.
  Veröffentlicht: (2024)
• Letter: Allostatic Load and Adverse Prognosis in Inflammatory Bowel Disease—Need More Evidence. Authors' Reply
  von: Jianhui Zhao, et al.
  Veröffentlicht: (2024)
• Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply
  von: Jianhui Zhao, et al.
  Veröffentlicht: (2024)